Educational information only — not a diagnosis or treatment recommendation.
Content last checked: Jul 15, 2026·Sources & review
Illustrative decision scenario
This is an editorial example used to show how patients compare options. It is not an account from an identified patient and should not be read as a verified personal testimony or outcome guarantee.
Illustrative decision journey · Singapore · 50-59
When a biomarker result changed the first treatment plan
Cancer type: Lung Cancer
Patient background
A patient with newly diagnosed non-small cell lung cancer was offered a surgery-first plan before molecular results returned.
Initial diagnosis
Suspected resectable NSCLC after staging imaging, with tissue sent for a broad biomarker panel that had not yet resulted.
Decision challenge
Whether to schedule resection immediately or wait a short, defined window for biomarker results that might favor systemic therapy first.
Options considered
- Proceed to surgery on the original calendar
- Wait for the tissue biomarker panel before locking sequencing
- Add liquid biopsy while waiting if turnaround was uncertain
Linked treatment comparisons
Why options were compared
The team explained that a targetable alteration could redirect first-line therapy and possibly change whether systemic treatment should come before surgery.
Final decision
Paused surgery for a time-boxed wait. An actionable alteration was found, and the plan shifted to a systemic-first sequence with surgery reconsidered after response assessment.
Lessons learned
- Ask what result would actually change the plan before agreeing to wait
- A short, dated pause is different from an open-ended delay
- Biomarker timing can turn a surgery-versus-systemic fork into a clearer sequence
Knowledge-graph connection
This story connects to
Illustrative scenario for Biomarker testing — use it to orient, then continue the decision path.
Decision node
Biomarker testing
Make sure pathology and molecular testing are complete enough to shape first-line choices — or decide when waiting is not safe.
Doctor questions / decision steps
Treatment comparison